Charlotte Smerdon

Charlotte Smerdon has extensive experience in the field of clinical operations and project management. Charlotte has held various senior roles in leading pharmaceutical companies such as Purespring Therapeutics, Veristat, Freeline, Gilead Sciences, GSK, Amgen, Biogen Idec, Takeda, and Stiefel.

At Purespring Therapeutics, they currently serve as the Senior Director of Clinical Operations. Charlotte is responsible for overseeing clinical operations and ensuring the smooth execution of projects.

Prior to that, at Veristat, Charlotte worked as the Portfolio Director and CGT and Rare Disease Center of Excellence Lead. In this role, they managed gene therapy programs, specialized in clinical development strategy, trial design, and non-classical route to market products. Charlotte also served as the main point of escalation for EU clients.

Before Veristat, Charlotte was the Director and Clinical Operations Program Lead at Freeline. Charlotte played a key role in developing and managing the Clinical Development Plan and worked on investigating a novel gene therapy for rare genetic diseases.

Charlotte'sprevious roles include serving as a Senior Clinical Trial Manager and Acting Program Manager at Gilead Sciences, where they coordinated and oversaw international phase I-III Virology studies. Charlotte has also worked as a Clinical Trial Manager at Gilead Sciences, a Project Manager in Clinical Operations at GSK, and a Director at VIGORMED LIMITED.

Throughout their career, Charlotte has demonstrated expertise in project management, trial oversight, study management, and compliance. Charlotte has a strong track record of driving study excellence, ensuring inspection readiness, and implementing process improvements.

Charlotte has a comprehensive understanding of the pharmaceutical industry and has worked on a range of therapeutic areas, including rare genetic diseases, virology, consumer health, nephrology, hemophilia, major depressive disease, and pediatrics.

Overall, Charlotte Smerdon is a highly skilled and experienced professional in clinical operations and project management with a diverse background in the pharmaceutical industry.

Charlotte Smerdon obtained a BSc in Applied Biology from the University of Hertfordshire, where they studied from 1998 to 2002. Charlotte then pursued a PhD in Cell Biology at UCL, completing their studies from 2002 to 2006.